SFES | Safeguard Scientifics, Inc. Annual & Quarterly

Annual Income Statements

(In USD)

Breakdown	2023	2022	2021	2020	2019	2018
Revenue	-	-	-	-	-	-
Cost of Revenue	319 Thousand	271 Thousand	229 Thousand	311 Thousand	1.06 Million	692 Thousand
Gross Profit	-319 Thousand	-271 Thousand	-229 Thousand	-311 Thousand	-1.06 Million	-692 Thousand
Operating Expenses	5.68 Million	4.5 Million	6.92 Million	9.15 Million	8.91 Million	16.17 Million
Selling, General and Administrative Expenses	5.36 Million	4.5 Million	6.92 Million	9.15 Million	8.91 Million	16.17 Million
Research and Development Expenses	-	-	-	-	-	-
Other Expenses	-	-3.29 Million	22.03 Million	-7.7 Million	-	-
Cost and Expenses	5.68 Million	4.77 Million	7.15 Million	9.46 Million	9.98 Million	16.87 Million
Operating Income	-5.68 Million	-4.77 Million	-7.15 Million	-9.46 Million	-9.98 Million	-16.87 Million
Interest Expense	-	-	-	-	14.02 Million	16.06 Million
Income Tax Expense	-	-	-	-	-	1.00
Earnings before Tax	-9.82 Million	-14.26 Million	27 Million	-37.61 Million	54.56 Million	-15.62 Million
Net Income	-9.82 Million	-14.26 Million	27 Million	-37.61 Million	54.56 Million	-15.62 Million
Earnings Per Share Basic	-0.61	-0.87	1.36	-1.81	2.64	-0.76
Earnings Per Share Diluted	-0.61	-0.87	1.36	-1.81	2.64	-0.76
Weighted Average Shares Outstanding	16.22 Million	16.33 Million	19.82 Million	20.75 Million	20.63 Million	20.54 Million
Weighted Average Shares Outstanding (Diluted)	16.22 Million	16.33 Million	19.82 Million	20.75 Million	20.63 Million	20.54 Million
Gross Margin	-	-	-	-	-	-
EBIT Margin	-	-	-	-	-	-
Profit Margin	-	-	-	-	-	-
EBITDA	-9.5 Million	-13.99 Million	27.23 Million	-37.3 Million	69.65 Million	-16.17 Million
Earnings Before Tax Margin	-	-	-	-	-	-

Breakdown	2024 Q2	2024 Q1	2023 Q4	2023 FY	2023 Q3	2023 Q2
Revenue	-	-	-	-	-	-
Cost of Revenue	-	-	319 Thousand	319 Thousand	-	-
Gross Profit	-	-	-319 Thousand	-319 Thousand	-	-
Operating Expenses	667 Thousand	950 Thousand	1.68 Million	5.36 Million	1.31 Million	986 Thousand
Selling, General and Administrative Expenses	667 Thousand	950 Thousand	1.68 Million	-	1.31 Million	986 Thousand
Research and Development Expenses	-	-	-	-	-	-
Other Expenses	-	-	551 Thousand	2.03 Million	1.66 Million	-166 Thousand
Cost and Expenses	667 Thousand	950 Thousand	1.99 Million	5.68 Million	1.31 Million	986 Thousand
Operating Income	-667 Thousand	-950 Thousand	-1.99 Million	-5.68 Million	-1.31 Million	-986 Thousand
Interest Expense	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-
Earnings before Tax	-1.7 Million	-2.01 Million	-4.41 Million	-9.82 Million	932 Thousand	-2.86 Million
Net Income	-1.7 Million	-2.01 Million	-4.41 Million	-9.82 Million	932 Thousand	-2.86 Million
Earnings Per Share Basic	-0.10	-0.12	-0.27	-	0.06	-0.18
Earnings Per Share Diluted	-0.10	-0.12	-0.27	-	0.06	-0.18
Weighted Average Shares Outstanding	16.54 Million	16.51 Million	16.62 Million	16.22 Million	16.28 Million	16.14 Million
Weighted Average Shares Outstanding (Diluted)	16.54 Million	16.51 Million	16.62 Million	16.22 Million	16.28 Million	16.14 Million
Gross Margin	-	-	-	-	-	-
EBIT Margin	-	-	-	-	-	-
Profit Margin	-	-	-	-	-	-
EBITDA	-667 Thousand	-950 Thousand	-1.68 Million	-	-1.31 Million	-986 Thousand
Earnings Before Tax Margin	-	-	-	-	-	-